We present a patient with congenital neutropenia resulting from bi-allelic variants in the catalytic subunit-3 of glucose-6-phosphatase [G6PC3] whose markers of systemic inflammation and symptoms of therapy-resistant Crohn’s disease resolved with HSCT. Here, G6PC1 is linked to severe congenital neutropenia.